Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Bio-Reference Laboratories Company Profile (NASDAQ:BRLI)

Consensus Ratings for Bio-Reference Laboratories (NASDAQ:BRLI) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $29.55 4.12% downside)

Analysts' Ratings History for Bio-Reference Laboratories (NASDAQ:BRLI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/6/2014ZacksUpgradeUnderperform -> Neutral$26.10ViewTweet This Rating  Share This Rating on StockTwits
1/20/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
12/10/2013Bank of AmericaReiterated RatingBuy$34.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2013ZacksDowngradeNeutral -> Underperform$24.30ViewTweet This Rating  Share This Rating on StockTwits
11/27/2013SidotiDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
7/10/2013William BlairDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Benchmark Co.Boost Price TargetBuy$32.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
3/1/2013Benchmark Co.Boost Price TargetBuy$32.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
12/7/2012Benchmark Co.Reiterated RatingBuy$30.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
12/7/2012MacquarieDowngradeNeutral -> Underperform$25.00ViewTweet This Rating  Share This Rating on StockTwits
10/3/2012B. RileyInitiated CoverageBuy$37.00ViewTweet This Rating  Share This Rating on StockTwits
8/31/2012Benchmark Co.Boost Price TargetBuy$27.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2012 forward)